198 related articles for article (PubMed ID: 10091618)
1. Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challenges.
Schrag A; Schelosky L; Scholz U; Poewe W
Mov Disord; 1999 Mar; 14(2):252-5. PubMed ID: 10091618
[TBL] [Abstract][Full Text] [Related]
2. Pramipexole, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease.
Künig G; Pogarell O; Möller JC; Delf M; Oertel WH
Clin Neuropharmacol; 1999; 22(5):301-5. PubMed ID: 10516884
[TBL] [Abstract][Full Text] [Related]
3. Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease.
Hellmann MA; Sabach T; Melamed E; Djaldetti R
Biomed Pharmacother; 2008; 62(4):250-2. PubMed ID: 17967525
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological treatment of parkinsonian tremor].
Yokochi F
Nihon Rinsho; 2000 Oct; 58(10):2091-5. PubMed ID: 11068452
[TBL] [Abstract][Full Text] [Related]
5. A cross-over clinical and electromyographic assessment of treatment for parkinsonian tremor.
Milanov I
Parkinsonism Relat Disord; 2001 Sep; 8(1):67-73. PubMed ID: 11472883
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG
Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
[TBL] [Abstract][Full Text] [Related]
7. Identifying poor symptom control in Parkinson's disease.
Scott L
Nurs Times; 2006 Mar 21-27; 102(12):30-2. PubMed ID: 16594560
[TBL] [Abstract][Full Text] [Related]
8. Drugs for Parkinson's disease reduce tremor induced by physostigmine.
Gothóni P; Lehtinen M; Fincke M
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):205-10. PubMed ID: 6621715
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
Sung YH; Chung SJ; Kim SR; Lee MC
Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of levodopa coadministered with apomorphine in parkinsonian patients with end-of-dose motor fluctuations.
Baas H; Harder S; Bürklin F; Demisch L; Fischer PA
Clin Neuropharmacol; 1998; 21(2):86-92. PubMed ID: 9579293
[TBL] [Abstract][Full Text] [Related]
11. Tremor and dopamine agonists.
Elble RJ
Neurology; 2002 Feb; 58(4 Suppl 1):S57-62. PubMed ID: 11909986
[TBL] [Abstract][Full Text] [Related]
12. Apomorphine-induced reorganization of striato-frontal connectivity in patients with tremor-dominant Parkinson's disease.
Nigro S; Bordier C; Cerasa A; Nisticò R; Olivadese G; Vescio B; Bianco MG; Fiorillo A; Barbagallo G; Crasà M; Quattrone A; Morelli M; Arabia G; Augimeri A; Nicolini C; Bifone A; Quattrone A
Parkinsonism Relat Disord; 2019 Oct; 67():14-20. PubMed ID: 31621599
[TBL] [Abstract][Full Text] [Related]
13. Motor asymmetry over time in Parkinson's disease.
Miller-Patterson C; Buesa R; McLaughlin N; Jones R; Akbar U; Friedman JH
J Neurol Sci; 2018 Oct; 393():14-17. PubMed ID: 30096567
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
Montastruc JL; Ziegler M; Rascol O; Malbezin M
Mov Disord; 1999 Mar; 14(2):336-41. PubMed ID: 10091630
[TBL] [Abstract][Full Text] [Related]
15. Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease.
Zach H; Dirkx MF; Roth D; Pasman JW; Bloem BR; Helmich RC
Neurology; 2020 Sep; 95(11):e1461-e1470. PubMed ID: 32651292
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Treatment of Tremor in Parkinson's Disease Revisited.
Pirker W; Katzenschlager R; Hallett M; Poewe W
J Parkinsons Dis; 2023; 13(2):127-144. PubMed ID: 36847017
[TBL] [Abstract][Full Text] [Related]
17. Apomorphine in patients with Parkinson's disease.
Muguet D; Broussolle E; Chazot G
Biomed Pharmacother; 1995; 49(4):197-209. PubMed ID: 7669939
[TBL] [Abstract][Full Text] [Related]
18. Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study.
Pogarell O; Gasser T; van Hilten JJ; Spieker S; Pollentier S; Meier D; Oertel WH
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):713-20. PubMed ID: 12023411
[TBL] [Abstract][Full Text] [Related]
19. Peripheral beta-adrenergic blockade treatment of parkinsonian tremor.
Foster NL; Newman RP; LeWitt PA; Gillespie MM; Larsen TA; Chase TN
Ann Neurol; 1984 Oct; 16(4):505-8. PubMed ID: 6149724
[TBL] [Abstract][Full Text] [Related]
20. Task Specific Tremor in Parkinson's Disease Responds to Apomorphine.
Ondo WG; Koneru V; Arif C
Tremor Other Hyperkinet Mov (N Y); 2023; 13():20. PubMed ID: 37275945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
